Cupid strengthens board with appointment of four new directors
Smeeta Bhatkal, Santosh Desai and Akshay Kumar join as Independent Directors; Shaina NC as Non-Executive Director
Smeeta Bhatkal, Santosh Desai and Akshay Kumar join as Independent Directors; Shaina NC as Non-Executive Director
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia
Puri is an accomplished leader and financial sector veteran with over four decades of experience
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
Exploring new opportunities within the fast-growing market of microfluidics
The transaction is expected to result in approximately $175 million to support further development of IMG-007
The investment will empower RDHL to develop a virtual diagnostic and care platform, expanding access to healthcare for underserved communities
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Subscribe To Our Newsletter & Stay Updated